This is nothing like the Cannabis boom in 2014... Seems much more serious. Take a look at some of these resources: https://www.fool.ca/2020/12/04/are-psychedelics-the-next-pot-stocks/ https://seekingalpha.com/article/4392873-mindmed-severely-undervalued-massive-upside-yet-to-come Company Website: https://www.mindmed.co/ Pipeline: Clinical Trial Data and Links Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin (LSD-psilo) https://clinicaltrials.gov/ct2/show/NCT04516902 Effects of MDMA Co-administration on the Response to LSD in Healthy Subjects (LSD-MDMA) https://clinicaltrials.gov/ct2/show/NCT04516902 PR: MindMed Announces the Completion of Phase 1 Study Measuring Dosing Effects of LSD https://www.prnewswire.com/news-rel...easuring-dosing-effects-of-lsd-301164518.html MindMed Announces $25 Million Bought Deal Public Offering https://www.newswire.ca/news-releas...on-bought-deal-public-offering-827003573.html MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines https://www.prnewswire.com/news-rel...edelic-therapies-and-medicines-301145393.html MindMed and Liechti Lab Announce R&D Collaboration On Psilocybin https://www.prnewswire.com/news-rel...rd-collaboration-on-psilocybin-301137184.html MindMed Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial Advisor https://www.prnewswire.com/news-rel...d-genuity-as-financial-advisor-301134414.html MindMed Announces First-Ever Clinical Trial Combining MDMA and LSD https://www.prnewswire.com/news-rel...l-trial-combining-mdma-and-lsd-301117559.html Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results https://www.prnewswire.com/news-rel...ncial-results-301112422.html?tc=eml_cleartime MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President https://www.prnewswire.com/news-rel...-as-president-301111575.html?tc=eml_cleartime MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy https://www.prnewswire.com/news-rel...-project-lucy-301107371.html?tc=eml_cleartime MindMed Completes Dosing 18-MC Phase 1 Study http://www.prnewswire.com/news-rele...phase-1-study-301100995.html?tc=eml_cleartime OTC Markets Link: https://www.otcmarkets.com/stock/MMEDF/overview
for all you penny players out there. ----- MindMed Surges Ahead Of Nasdaq Debut 1:15 pm ET April 26, 2021 (Benzinga) Print Clinical-stage psychedelic medicine and biotech company Mind Medicine Inc (OTC: MMEDF), also known as MindMed, is surging again Monday ahead of its Nasdaq debut. The company's mission is "to discover, develop and deploy psychedelic inspired medicines and therapies to address addiction and mental illness," according to CEO J.R. Rahn. Mind Medicine announced last Friday it will be uplisted to the Nasdaq on Tuesday, leading to a 40% rise in share price. “The listing of our stock on the Nasdaq represents a significant milestone in our growth as a publicly-traded company,” Rahn said in a press release. "We believe this listing will increase our visibility in the marketplace, improve liquidity, broaden and diversify our shareholder base, and ultimately enhance long-term shareholder value." See Also: How MindMed Uses Tech To Innovate, Deploy Psychedelic Mental Health Therapies Trading will begin Tuesday on the Nasdaq under the new ticker symbol "MNMD." Rahn will appear on Benzinga's "Power Hour" show Thursday afternoon. MindMed's stock is up another 36% to $4.80 at the time of publication. © 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
